The pregabalin clinical programme involved over 9000 patients who were exposed to pregabalin, of whom over 5000 were in double-blind placebo controlled trials.
Pregabaliini kliinilises programmis osales üle 9000 pregabaliini saanud patsiendi, kellest üle 5000 patsiendi osalesid topeltpimedates platseebokontrolliga uuringutes.